MA27467A1 - Quinolones anti-microbiens, leurs compositions et utilisations - Google Patents

Quinolones anti-microbiens, leurs compositions et utilisations

Info

Publication number
MA27467A1
MA27467A1 MA28065A MA28065A MA27467A1 MA 27467 A1 MA27467 A1 MA 27467A1 MA 28065 A MA28065 A MA 28065A MA 28065 A MA28065 A MA 28065A MA 27467 A1 MA27467 A1 MA 27467A1
Authority
MA
Morocco
Prior art keywords
microbial
quinolones
compositions
compounds
effective
Prior art date
Application number
MA28065A
Other languages
English (en)
Inventor
Benoit Ledoussal
Xiufeng Eric Hu
Ji-In Kim Almstead
Jeffrey Lyle Gray
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA27467A1 publication Critical patent/MA27467A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Les composés de la formule suivante (I) sont efficaces en tant qu'agents anti-microbiens.
MA28065A 2002-07-31 2005-01-25 Quinolones anti-microbiens, leurs compositions et utilisations MA27467A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31

Publications (1)

Publication Number Publication Date
MA27467A1 true MA27467A1 (fr) 2005-08-01

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28065A MA27467A1 (fr) 2002-07-31 2005-01-25 Quinolones anti-microbiens, leurs compositions et utilisations

Country Status (17)

Country Link
US (1) US6900224B2 (fr)
EP (1) EP1532137A2 (fr)
JP (1) JP2005536532A (fr)
KR (1) KR20050026074A (fr)
CN (1) CN1671690A (fr)
AU (1) AU2003259169A1 (fr)
BR (1) BR0313420A (fr)
CA (1) CA2493146A1 (fr)
IL (1) IL166041A0 (fr)
MA (1) MA27467A1 (fr)
MX (1) MXPA05001180A (fr)
NO (1) NO20051082L (fr)
NZ (1) NZ537203A (fr)
PL (1) PL375388A1 (fr)
RU (1) RU2005105337A (fr)
WO (1) WO2004014893A2 (fr)
ZA (1) ZA200500877B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1264837C (zh) * 1997-09-15 2006-07-19 普罗克特和甘保尔公司 喹诺酮抗微生物剂、其组合物和应用
ATE395920T1 (de) * 1999-12-28 2008-06-15 Teikoku Seiyaku Kk Wirkstoffe gegen pruritus zum äusserlichen gebrauch
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
US7163948B2 (en) * 2003-04-07 2007-01-16 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
JP2006522827A (ja) * 2003-04-07 2006-10-05 サイリーン ファーマシューティカルズ インコーポレーティッド 置換キノベンゾオキサジン類似体
NZ553746A (en) * 2004-09-17 2010-06-25 Cylene Pharmaceuticals Inc Quinolone analogs as cell proliferation inhibitors
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
ES2366150T3 (es) * 2006-03-28 2011-10-17 Warner Chilcott Company, Llc Malatos de polimorfos de ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinocarboxílico.
BRPI0709209A2 (pt) * 2006-03-28 2011-06-28 Procter & Gamble processo de redução de hidreto para preparo de intermediários de quinolona
CA2647454A1 (fr) 2006-03-28 2007-10-04 The Procter & Gamble Company Procede de couplage pour preparer des intermediaires quinolone
CN101595109B (zh) * 2006-11-20 2012-09-05 百时美施贵宝公司 作为二肽基肽酶ⅳ抑制剂的7，8-二氢-1，6-二氮杂萘-5（6h）-酮和相关二环化合物及方法
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
KR101601332B1 (ko) 2007-10-05 2016-03-08 센화 바이오사이언시즈 인코포레이티드 퀴놀론 유사체 및 이와 관련된 방법
AU2008358909B2 (en) * 2008-07-01 2012-12-13 Taigen Biotechnology Co., Ltd. Treatment of antibiotic-resistant bacteria infection
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
EA022785B8 (ru) * 2008-12-15 2016-06-30 Тайджен Байотекнолоджи Ко., Лтд. Стереоселективный синтез производных пиперидина
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
CN119185322A (zh) 2015-11-20 2024-12-27 生华生物科技股份有限公司 用于治疗癌症的四环喹诺酮类似物组合疗法
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
EP3394061B1 (fr) 2015-12-23 2020-03-11 Merck Sharp & Dohme Corp. Modulateurs allostériques 6,7-dihydro-5h-pyrrolo[3,4-b]pyridine-5-one du récepteur de l'acétylcholine muscarinique m4
WO2017107089A1 (fr) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. Modulateurs allostériques 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2018112843A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine du récepteur muscarinique de l'acétylcholine m4
WO2018112842A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine 6,6-fusionné du récepteur muscarinique de l'acétylcholine m4
WO2018112840A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther d'hétéroarylpipéridine 6, 5-fusionnés du récepteur muscarinique d'acétylcholine m4
WO2019000238A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 5-(pyridin-3-yl)oxazole du récepteur muscarinique m4 de l'acétylcholine
WO2019000237A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2019000236A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
EP3752149A4 (fr) 2018-02-15 2022-03-02 Senhwa Biosciences, Inc. Analogues de quinolone, sels correspondants, compositions et procédé d'utilisation
ES2956316T3 (es) * 2018-04-25 2023-12-19 Elanco Animal Health Gmbh Proceso para la hidrólisis de ésteres carboxílicos de quinolona
CN121517697A (zh) * 2025-11-21 2026-02-13 华南理工大学 一种抗菌聚肽高分子材料、包含其的产品及制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0342675B1 (fr) 1988-05-19 1995-01-25 Chugai Seiyaku Kabushiki Kaisha Dérivés de l'acide quinolonecarboxylique
ATE217309T1 (de) * 1993-10-14 2002-05-15 Abbott Lab Verbindungen des chinolizinon-typs
KR19990022524A (ko) * 1995-06-06 1999-03-25 웨인스톡 스티븐 에프. 퀴놀리지논형화합물
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
CN1264837C (zh) * 1997-09-15 2006-07-19 普罗克特和甘保尔公司 喹诺酮抗微生物剂、其组合物和应用
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GEP20053429B (en) * 2000-01-24 2005-01-25 Warner Lambert Co 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
ATE304539T1 (de) 2000-12-14 2005-09-15 Procter & Gamble Antimikrobielle chinolone

Also Published As

Publication number Publication date
BR0313420A (pt) 2005-06-28
AU2003259169A1 (en) 2004-02-25
US6900224B2 (en) 2005-05-31
NZ537203A (en) 2007-02-23
RU2005105337A (ru) 2006-01-20
CN1671690A (zh) 2005-09-21
WO2004014893A2 (fr) 2004-02-19
WO2004014893A3 (fr) 2004-04-08
US20040038975A1 (en) 2004-02-26
NO20051082L (no) 2005-04-29
KR20050026074A (ko) 2005-03-14
JP2005536532A (ja) 2005-12-02
EP1532137A2 (fr) 2005-05-25
CA2493146A1 (fr) 2004-02-19
ZA200500877B (en) 2006-02-20
IL166041A0 (en) 2006-01-15
PL375388A1 (en) 2005-11-28
MXPA05001180A (es) 2005-05-16

Similar Documents

Publication Publication Date Title
BR0313420A (pt) Quinolonas microbicidas, suas composições e usos
BR0107811A (pt) Composição herbicida
TR200101126T2 (tr) İkameli fenil türevleri, hazırlanma ve kullanımları
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
MA27643A1 (fr) Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
DE60324544D1 (de) Muskarin antagonisten
HRP20030383B1 (hr) Laktamski spoj
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
DK0897904T3 (da) Fungicide 2-methoxybenzophenoner
MA27180A1 (fr) N-aryl-2-oxazolidinone-5-carboxamides et leurs derives, et leur utilisation comme agents antibacteriens
DK1200418T3 (da) Nematodicide trifluorbutener
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
ES2243579T3 (es) Derivados de pirazolopirideno.
BR0116319A (pt) Composição herbicida
BR0105563A (pt) Derivados e análogos de galantamina
DK1531672T3 (da) Antimikrobielle sammensætninger
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
NO20002408D0 (no) 5-HT1F antagonister
BR0116205A (pt) 2-piridonas antimicrobianas, suas composições e usos
TR200402343T4 (tr) Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
EP1458706A4 (fr) Derives de diaryle 1,2,4-triazole en tant qu'inhibiteur hautement selectif de cyclooxygenase-2